Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Parameters of Time-out: Research Update and Comparison to Parenting Programs, Books, and Online Recommendations.

Corralejo SM, Jensen SA, Greathouse AD, Ward LE.

Behav Ther. 2018 Jan;49(1):99-112. doi: 10.1016/j.beth.2017.09.005. Epub 2017 Sep 14. Review.

PMID:
29405925
2.

Optically induced metastability in Cu(In,Ga)Se2.

Jensen SA, Kanevce A, Mansfield LM, Glynn S, Lany S, Kuciauskas D.

Sci Rep. 2017 Oct 23;7(1):13788. doi: 10.1038/s41598-017-14344-6.

3.

Structured Feedback Training for Time-Out: Efficacy and Efficiency in Comparison to a Didactic Method.

Jensen SA, Blumberg S, Browning M.

Behav Modif. 2018 Sep;42(5):765-780. doi: 10.1177/0145445517733474. Epub 2017 Sep 29.

PMID:
28962539
4.

The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1.

Robertson IB, Dias HF, Osuch IH, Lowe ED, Jensen SA, Redfield C, Handford PA.

Structure. 2017 Aug 1;25(8):1208-1221.e5. doi: 10.1016/j.str.2017.06.003. Epub 2017 Jun 29.

5.

Food allergies in the elderly: Collecting the evidence.

Jensen-Jarolim E, Jensen SA.

Ann Allergy Asthma Immunol. 2016 Nov;117(5):472-475. doi: 10.1016/j.anai.2016.08.036. Epub 2016 Oct 24. Review. No abstract available.

6.

Engagement in Behavioral Parent Training: Review of the Literature and Implications for Practice.

Chacko A, Jensen SA, Lowry LS, Cornwell M, Chimklis A, Chan E, Lee D, Pulgarin B.

Clin Child Fam Psychol Rev. 2016 Sep;19(3):204-15. doi: 10.1007/s10567-016-0205-2. Review.

PMID:
27311693
7.

The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases.

Dillekås H, Demicheli R, Ardoino I, Jensen SA, Biganzoli E, Straume O.

Breast Cancer Res Treat. 2016 Jul;158(1):169-78. doi: 10.1007/s10549-016-3857-1. Epub 2016 Jun 15.

8.

New insights into the structure, assembly and biological roles of 10-12 nm connective tissue microfibrils from fibrillin-1 studies.

Jensen SA, Handford PA.

Biochem J. 2016 Apr 1;473(7):827-38. doi: 10.1042/BJ20151108. Review.

PMID:
27026396
9.

Phonon-Electron Scattering Limits Free Charge Mobility in Methylammonium Lead Iodide Perovskites.

Karakus M, Jensen SA, D'Angelo F, Turchinovich D, Bonn M, Cánovas E.

J Phys Chem Lett. 2015 Dec 17;6(24):4991-6. doi: 10.1021/acs.jpclett.5b02485. Epub 2015 Dec 4.

PMID:
26619006
10.

Caution: Reptile pets shuttle grasshopper allergy and asthma into homes.

Jensen-Jarolim E, Pali-Schöll I, Jensen SA, Robibaro B, Kinaciyan T.

World Allergy Organ J. 2015 Aug 17;8(1):24. doi: 10.1186/s40413-015-0072-1. eCollection 2015.

11.

Thermodynamic picture of ultrafast charge transport in graphene.

Mics Z, Tielrooij KJ, Parvez K, Jensen SA, Ivanov I, Feng X, Müllen K, Bonn M, Turchinovich D.

Nat Commun. 2015 Jul 16;6:7655. doi: 10.1038/ncomms8655.

12.

A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias.

Jensen SA, Iqbal S, Bulsiewicz A, Handford PA.

Hum Mol Genet. 2015 Aug 1;24(15):4454-63. doi: 10.1093/hmg/ddv181. Epub 2015 May 15.

13.

Bottom-up synthesis of liquid-phase-processable graphene nanoribbons with near-infrared absorption.

Narita A, Verzhbitskiy IA, Frederickx W, Mali KS, Jensen SA, Hansen MR, Bonn M, De Feyter S, Casiraghi C, Feng X, Müllen K.

ACS Nano. 2014 Nov 25;8(11):11622-30. doi: 10.1021/nn5049014. Epub 2014 Oct 28.

PMID:
25338208
14.

Competing ultrafast energy relaxation pathways in photoexcited graphene.

Jensen SA, Mics Z, Ivanov I, Varol HS, Turchinovich D, Koppens FH, Bonn M, Tielrooij KJ.

Nano Lett. 2014 Oct 8;14(10):5839-45. doi: 10.1021/nl502740g. Epub 2014 Sep 25.

PMID:
25247639
15.

C-terminal propeptide is required for fibrillin-1 secretion and blocks premature assembly through linkage to domains cbEGF41-43.

Jensen SA, Aspinall G, Handford PA.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10155-60. doi: 10.1073/pnas.1401697111. Epub 2014 Jun 30.

16.

Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.

Jensen SA, Calvert AE, Volpert G, Kouri FM, Hurley LA, Luciano JP, Wu Y, Chalastanis A, Futerman AH, Stegh AH.

Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5682-7. doi: 10.1073/pnas.1316700111. Epub 2014 Mar 31.

17.

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C, Nicholson G, Gonzalez-Neira A, Martin M, Sargent D, Green E, McLeod H, Zanger UM, Schwab M, Braun M, Seymour M, Thompson L, Lacas B, Boige V, Ribelles N, Afzal S, Enghusen H, Jensen SA, Etienne-Grimaldi MC, Milano G, Wadelius M, Glimelius B, Garmo H, Gusella M, Lecomte T, Laurent-Puig P, Martinez-Balibrea E, Sharma R, Garcia-Foncillas J, Kleibl Z, Morel A, Pignon JP, Midgley R, Kerr D, Tomlinson I.

J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857. Epub 2014 Mar 3. Review.

18.

Synthesis of structurally well-defined and liquid-phase-processable graphene nanoribbons.

Narita A, Feng X, Hernandez Y, Jensen SA, Bonn M, Yang H, Verzhbitskiy IA, Casiraghi C, Hansen MR, Koch AH, Fytas G, Ivasenko O, Li B, Mali KS, Balandina T, Mahesh S, De Feyter S, Müllen K.

Nat Chem. 2014 Feb;6(2):126-32. doi: 10.1038/nchem.1819. Epub 2013 Dec 8.

PMID:
24451588
19.

Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.

Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, Daniel WL, Scott AW, Rotz MW, Meade TJ, Giljohann DA, Mirkin CA, Stegh AH.

Sci Transl Med. 2013 Oct 30;5(209):209ra152. doi: 10.1126/scitranslmed.3006839.

20.

Ultrafast photoconductivity of graphene nanoribbons and carbon nanotubes.

Jensen SA, Ulbricht R, Narita A, Feng X, Müllen K, Hertel T, Turchinovich D, Bonn M.

Nano Lett. 2013;13(12):5925-30. doi: 10.1021/nl402978s. Epub 2013 Nov 7.

PMID:
24093134
21.

Structure of the fibrillin-1 N-terminal domains suggests that heparan sulfate regulates the early stages of microfibril assembly.

Yadin DA, Robertson IB, McNaught-Davis J, Evans P, Stoddart D, Handford PA, Jensen SA, Redfield C.

Structure. 2013 Oct 8;21(10):1743-56. doi: 10.1016/j.str.2013.08.004. Epub 2013 Sep 12.

22.

On 5-fluorouracil therapy of colorectal cancer.

Jensen SA.

Dan Med J. 2013 Jul;60(7):B4603. No abstract available.

PMID:
23809976
23.

Juvenile idiopathic arthritis, mitral valve prolapse and a familial variant involving the integrin-binding fragment of FBN1.

Wilson BT, Jensen SA, McAnulty CP, Brennan P, Handford PA.

Am J Med Genet A. 2013 Aug;161A(8):2047-51. doi: 10.1002/ajmg.a.36011. Epub 2013 Jun 21.

PMID:
23794388
24.

¹H, ¹³C and ¹⁵N resonance assignments for the fibrillin-1 EGF2-EGF3-hybrid1-cbEGF1 four-domain fragment.

Robertson IB, Osuch I, Yadin DA, Handford PA, Jensen SA, Redfield C.

Biomol NMR Assign. 2014 Apr;8(1):189-94. doi: 10.1007/s12104-013-9481-7. Epub 2013 May 7.

25.

¹H, ¹³C and ¹⁵N assignments of the four N-terminal domains of human fibrillin-1.

Yadin DA, Robertson IB, Jensen SA, Handford PA, Redfield C.

Biomol NMR Assign. 2014 Apr;8(1):75-80. doi: 10.1007/s12104-012-9456-0. Epub 2012 Dec 23.

26.

Payment schedules do not affect attendance/completion of group behavioral parent training.

Jensen SA, Lowry LS.

Psychol Serv. 2012 Feb;9(1):101-9. doi: 10.1037/a0027101.

PMID:
22449091
27.

Data-driven assessment of the association of polymorphisms in 5-Fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer.

Sarac SB, Rasmussen CH, Afzal S, Thirstrup S, Jensen SA, Colding-Jørgensen M, Poulsen HE, Mosekilde E.

Basic Clin Pharmacol Toxicol. 2012 Sep;111(3):189-97. doi: 10.1111/j.1742-7843.2012.00885.x. Epub 2012 Apr 16.

28.

The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond.

Kouri FM, Jensen SA, Stegh AH.

ScientificWorldJournal. 2012;2012:838916. doi: 10.1100/2012/838916. Epub 2012 Feb 14. Review.

29.

Dissecting the fibrillin microfibril: structural insights into organization and function.

Jensen SA, Robertson IB, Handford PA.

Structure. 2012 Feb 8;20(2):215-25. doi: 10.1016/j.str.2011.12.008. Review.

30.

Size-dependent electron transfer from PbSe quantum dots to SnO2 monitored by picosecond Terahertz spectroscopy.

Cánovas E, Moll P, Jensen SA, Gao Y, Houtepen AJ, Siebbeles LD, Kinge S, Bonn M.

Nano Lett. 2011 Dec 14;11(12):5234-9. doi: 10.1021/nl202550v. Epub 2011 Nov 2.

PMID:
22040524
31.

The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer.

Afzal S, Gusella M, Jensen SA, Vainer B, Vogel U, Andersen JT, Brødbæk K, Petersen M, Jimenez-Solem E, Adleff V, Budai B, Hitre E, Láng I, Orosz E, Bertolaso L, Barile C, Padrini R, Kralovánszky J, Pasini F, Poulsen HE.

Pharmacogenomics. 2011 Sep;12(9):1257-67. doi: 10.2217/pgs.11.83.

PMID:
21919605
32.

Oxidative damage to guanine nucleosides following combination chemotherapy with 5-fluorouracil and oxaliplatin.

Afzal S, Jensen SA, Sørensen JB, Henriksen T, Weimann A, Poulsen HE.

Cancer Chemother Pharmacol. 2012 Feb;69(2):301-7. doi: 10.1007/s00280-011-1700-2. Epub 2011 Jun 28.

PMID:
21710244
33.

5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.

Jensen SA, Sørensen JB.

Cancer Chemother Pharmacol. 2012 Jan;69(1):57-64. doi: 10.1007/s00280-011-1669-x. Epub 2011 May 21.

PMID:
21603868
34.

Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patients.

Afzal S, Gusella M, Vainer B, Vogel UB, Andersen JT, Broedbaek K, Petersen M, Jimenez-Solem E, Bertolaso L, Barile C, Padrini R, Pasini F, Jensen SA, Poulsen HE.

Clin Cancer Res. 2011 Jun 1;17(11):3822-9. doi: 10.1158/1078-0432.CCR-11-0304. Epub 2011 Apr 6.

35.

Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.

Jensen SA, Hasbak P, Mortensen J, Sørensen JB.

J Clin Oncol. 2010 Dec 20;28(36):5280-6. doi: 10.1200/JCO.2009.27.3953. Epub 2010 Nov 15.

PMID:
21079148
36.

Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.

Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S, Yu J, Frost JA, Corey SJ.

Cancer Res. 2010 Nov 1;70(21):8347-56. doi: 10.1158/0008-5472.CAN-09-4149. Epub 2010 Oct 12.

37.
38.

Biophysical characterisation of fibulin-5 proteins associated with disease.

Schneider R, Jensen SA, Whiteman P, McCullagh JS, Redfield C, Handford PA.

J Mol Biol. 2010 Aug 27;401(4):605-17. doi: 10.1016/j.jmb.2010.06.039. Epub 2010 Jun 25.

PMID:
20599547
39.

[Treatment of serious burns].

Guttormsen AB, Onarheim H, Thorsen J, Jensen SA, Rosenberg BE.

Tidsskr Nor Laegeforen. 2010 Jun 17;130(12):1236-41. doi: 10.4045/tidsskr.08.0391. Review. Norwegian.

40.

[Cardiotoxicity induced by 5-fluorouracil or capecitabine].

Jensen SA, Baeksgaard L, Petersen LN, Reiter L, Sørensen JB.

Ugeskr Laeger. 2010 Jan 4;172(1):48-51. Danish.

PMID:
20056096
41.

Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.

Makepeace BL, Jensen SA, Laney SJ, Nfon CK, Njongmeta LM, Tanya VN, Williams SA, Bianco AE, Trees AJ.

PLoS Negl Trop Dis. 2009 Nov 10;3(11):e544. doi: 10.1371/journal.pntd.0000544.

42.

The epidemiology of patients with burn injuries admitted to Norwegian hospitals in 2007.

Onarheim H, Jensen SA, Rosenberg BE, Guttormsen AB.

Burns. 2009 Dec;35(8):1142-6. doi: 10.1016/j.burns.2009.06.191. Epub 2009 Sep 12.

PMID:
19748742
43.

Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.

Thorsen S, Teisner A, Jensen SA, Philips M, Dalhoff K, Bendtsen F.

Scand J Clin Lab Invest. 2009;69(6):643-50. doi: 10.3109/00365510902943262.

PMID:
19530032
44.

Cleft lip and palate: association with other congenital malformations.

Beriaghi S, Myers SL, Jensen SA, Kaimal S, Chan CM, Schaefer GB.

J Clin Pediatr Dent. 2009 Spring;33(3):207-10.

PMID:
19476092
45.

MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer.

Afzal S, Jensen SA, Vainer B, Vogel U, Matsen JP, Sørensen JB, Andersen PK, Poulsen HE.

Ann Oncol. 2009 Oct;20(10):1660-6. doi: 10.1093/annonc/mdp046. Epub 2009 May 22.

PMID:
19465420
46.

Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/LTBP superfamily of matrix proteins.

Jensen SA, Iqbal S, Lowe ED, Redfield C, Handford PA.

Structure. 2009 May 13;17(5):759-68. doi: 10.1016/j.str.2009.03.014.

47.

College students' attitudes toward their ADHD peers.

Chew BL, Jensen SA, Rosén LA.

J Atten Disord. 2009 Nov;13(3):271-6. doi: 10.1177/1087054709333347. Epub 2009 May 8.

PMID:
19429881
48.

Non-invasive body temperature measurement of wild chimpanzees using fecal temperature decline.

Jensen SA, Mundry R, Nunn CL, Boesch C, Leendertz FH.

J Wildl Dis. 2009 Apr;45(2):542-6.

PMID:
19395769
49.

Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression.

Jensen SA, Vainer B, Kruhøffer M, Sørensen JB.

BMC Cancer. 2009 Jan 20;9:25. doi: 10.1186/1471-2407-9-25.

50.

The association between diabetes mellitus and the prevalence of intermittent claudication: the HUNT study.

Jensen SA, Vatten LJ, Myhre HO.

Vasc Med. 2008 Nov;13(4):239-44. doi: 10.1177/1358863X08094800.

PMID:
18940899

Supplemental Content

Loading ...
Support Center